Vectura Launches Flutiform Inhaler In The UK, Europe To Follow

LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK.

The company said it expects further launches across Europe to follow in the coming months.

Executive Vice President Geraldine Venthoye said: "Uncontrolled asthma is commonly associated with incorrect inhaler technique, coupled with poor adherence to therapy. The launch of this enhanced device, designed to help patients take their medicine and reduce critical errors, is a natural extension of the flutiform franchise.

"Europe remains a competitive and challenging market and the launch of the flutiform k-haler will help support continued growth."

Vectura shares were trading down 0.5% at 73.70 pence each.